Clinical trialNCT02160626CompletedPhase 2Interventional

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

SponsorAclaris Therapeutics, Inc.Enrollment172Seborrheic Keratosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101 solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Andrew Blauvelt, MD, MBA
Oregon Medical Research Center
Principal Investigator
clinicaltrials.gov ↗
Daniel M Stewart, DO
Michigan Center for Research Corp.
Principal Investigator
clinicaltrials.gov ↗
David C Wilson, MD
The Education & Research Foundation, Inc.
Principal Investigator
clinicaltrials.gov ↗
Janet Dubois, MD
Derm Research, PLLC
Principal Investigator
clinicaltrials.gov ↗
Jonathan S Weiss, MD
Gwinnett Clinical Research Center, Inc.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Gwinnett Clinical Research Center, Inc.
Snellville, Georgia, United States
Michigan Center for Research Corp.
Clinton Township, Michigan, United States
Oregon Medical Research Center
Portland, Oregon, United States
Dermreseach, Inc.
Austin, Texas, United States
the Education & Research Foundation, Inc.
Lynchburg, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

A-101 Topical SolutionA-101 Vehicle

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2014
Primary completion: 31 Dec 2014
Completion: 31 Dec 2014
Last update posted: 3 Jan 2019
Registered enrollment: 172
Registry id: NCT02160626

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.